BioCentury | Aug 20, 2020
Finance

Science 37, Castor raise funds as decentralized trials gain traction

...By Virginia Li, Associate Editor Science 37 and Castor each raised venture funding this week to expand...
...the logistical barriers to participation (see ““Can the Vogue of Decentralized Trials Continue Beyond the Pandemic?”).Science 37 Inc....
...more than 200 COVID-19 studies are running on the platform, including the WHO’s SOLIDARITY trial. Virginia Li Science 37 Inc. Castor decentralized...
BioCentury | Jul 31, 2020
Product Development

Can the vogue of decentralized trials continue beyond the pandemic?

...up the adoption of fully decentralized trials,” said Darcy Forman, SVP of clinical operations at Science 37 Inc....
...would also save companies time and costs associated with transporting patients to centers. Forman said Science 37...
...CRO with expertise in decentralized trials, remote monitoring and other digital technologies. Companies such as Science 37...
BioCentury | May 29, 2020
Management Tracks

Delaney takes over as Assembly’s CSO; plus NGM, TCR2, Amunix, Evox, Vor and more

...Oncology Inc. (NASDAQ:SRRA). He was CEO of Aimmune Therapeutics Inc. (NASDAQ:AIMT). Virtual clinical trial company Science 37 Inc....
...Inc. NGM Biopharmaceuticals Inc. TCR2 Therapeutics Inc. Amunix Pharmaceuticals Inc. Evox Therapeutics Ltd. Vor Biopharma Inc. BrainStorm Cell Therapeutics Inc. Sierra Oncology Inc. Science 37 Inc. Histogen...
BioCentury | May 28, 2020
Management Tracks

Quick departure for Semerjian as Immunomedics CEO; plus Ziopharm, Kinnate, Applied Therapeutics, Relmada, AskBio and more

...firm’s soon-to-be-opened San Francisco office. Robin Sawka, BioCentury Staff Asklepios BioPharmaceutical Inc. Seer Inc. Meridian Biopharmaceuticals Liquidia Technologies Inc. Amphista Therapeutics Ltd. Science 37 Inc. Amylyx...
BioCentury | Nov 23, 2019
Company News

Management tracks: Sanofi head of strategy Mansuri set to retire; plus Arrakis, MorphoSys, Kymera, Kronos, Kite, Twist, Cerevel, Coda, Science 37, and more

...director of pharmacology (see “Coda’s Chemogenetics Convinces Investors to Re-Up” ). Decentralized clinical trial company Science 37 Inc....
...Writer Sanofi MorphoSys AG Kymera Therapeutics Inc. Kronos Bio Inc. Arrakis Therapeutics Inc. Coda Biotherapeutics Inc. Kite Pharma Inc. Cerevel Therapeutics LLC Twist Bioscience Corp. Science 37 Inc. Progenics...
BioCentury | Sep 19, 2019
Politics & Policy

FDA opens doors for digital tools to facilitate siteless trials, find new endpoints

...Sanofi (Euronext:SAN; NASDAQ:SNY) have started to adopt these technologies through partnerships with companies such as Science 37 Inc....
...TrialSpark (New York, N.Y.) (see " A Year of Digital Progress at Novartis" & "UCB, Science 37...
BioCentury | Jun 18, 2019
Company News

Google partnership latest in Sanofi's quest to integrate digital throughout its business

...Sanofi has been expanding its digital footprint in recent years. In 2017, it partnered with Science 37...
BioCentury | Jun 8, 2019
Product Development

ASCO 2019 sessions provide guidance on expanding patient pools for clinical trials

...burden of travel. The group includes members from Amgen Inc., Roche, Roche's Genentech Inc. Unit, Science 37 Inc....
...and Sanofi have started to adopt technologies enabling site-less trials through partnerships with companies including Science 37...
...AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NASDAQ:SNY), Paris, France Science 37 Inc....
BioCentury | Dec 22, 2018
Product Development

A year of digital progress at Novartis

...digital therapeutics to improve outcomes in patients with multiple sclerosis, schizophrenia Product March Science 37 Inc. Use Science 37's...
...vs. three to six months,” Liu told BioCentury. The partnership complements a March deal with Science 37 Inc....
...SIX:NOVN), Basel, Switzerland Pear Therapeutics Inc., Boston, Mass. Proteus Digital Health Inc., Redwood City, Calif. Science 37 Inc....
BioCentury | Dec 14, 2018
Company News

Novartis expands patient recruitment capabilities in deal with TrialSpark

...and will initially evaluate an ankylosing spondylitis treatment. Last year, Novartis expanded a collaboration with Science 37 Inc....
Items per page:
1 - 10 of 23
BioCentury | Aug 20, 2020
Finance

Science 37, Castor raise funds as decentralized trials gain traction

...By Virginia Li, Associate Editor Science 37 and Castor each raised venture funding this week to expand...
...the logistical barriers to participation (see ““Can the Vogue of Decentralized Trials Continue Beyond the Pandemic?”).Science 37 Inc....
...more than 200 COVID-19 studies are running on the platform, including the WHO’s SOLIDARITY trial. Virginia Li Science 37 Inc. Castor decentralized...
BioCentury | Jul 31, 2020
Product Development

Can the vogue of decentralized trials continue beyond the pandemic?

...up the adoption of fully decentralized trials,” said Darcy Forman, SVP of clinical operations at Science 37 Inc....
...would also save companies time and costs associated with transporting patients to centers. Forman said Science 37...
...CRO with expertise in decentralized trials, remote monitoring and other digital technologies. Companies such as Science 37...
BioCentury | May 29, 2020
Management Tracks

Delaney takes over as Assembly’s CSO; plus NGM, TCR2, Amunix, Evox, Vor and more

...Oncology Inc. (NASDAQ:SRRA). He was CEO of Aimmune Therapeutics Inc. (NASDAQ:AIMT). Virtual clinical trial company Science 37 Inc....
...Inc. NGM Biopharmaceuticals Inc. TCR2 Therapeutics Inc. Amunix Pharmaceuticals Inc. Evox Therapeutics Ltd. Vor Biopharma Inc. BrainStorm Cell Therapeutics Inc. Sierra Oncology Inc. Science 37 Inc. Histogen...
BioCentury | May 28, 2020
Management Tracks

Quick departure for Semerjian as Immunomedics CEO; plus Ziopharm, Kinnate, Applied Therapeutics, Relmada, AskBio and more

...firm’s soon-to-be-opened San Francisco office. Robin Sawka, BioCentury Staff Asklepios BioPharmaceutical Inc. Seer Inc. Meridian Biopharmaceuticals Liquidia Technologies Inc. Amphista Therapeutics Ltd. Science 37 Inc. Amylyx...
BioCentury | Nov 23, 2019
Company News

Management tracks: Sanofi head of strategy Mansuri set to retire; plus Arrakis, MorphoSys, Kymera, Kronos, Kite, Twist, Cerevel, Coda, Science 37, and more

...director of pharmacology (see “Coda’s Chemogenetics Convinces Investors to Re-Up” ). Decentralized clinical trial company Science 37 Inc....
...Writer Sanofi MorphoSys AG Kymera Therapeutics Inc. Kronos Bio Inc. Arrakis Therapeutics Inc. Coda Biotherapeutics Inc. Kite Pharma Inc. Cerevel Therapeutics LLC Twist Bioscience Corp. Science 37 Inc. Progenics...
BioCentury | Sep 19, 2019
Politics & Policy

FDA opens doors for digital tools to facilitate siteless trials, find new endpoints

...Sanofi (Euronext:SAN; NASDAQ:SNY) have started to adopt these technologies through partnerships with companies such as Science 37 Inc....
...TrialSpark (New York, N.Y.) (see " A Year of Digital Progress at Novartis" & "UCB, Science 37...
BioCentury | Jun 18, 2019
Company News

Google partnership latest in Sanofi's quest to integrate digital throughout its business

...Sanofi has been expanding its digital footprint in recent years. In 2017, it partnered with Science 37...
BioCentury | Jun 8, 2019
Product Development

ASCO 2019 sessions provide guidance on expanding patient pools for clinical trials

...burden of travel. The group includes members from Amgen Inc., Roche, Roche's Genentech Inc. Unit, Science 37 Inc....
...and Sanofi have started to adopt technologies enabling site-less trials through partnerships with companies including Science 37...
...AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NASDAQ:SNY), Paris, France Science 37 Inc....
BioCentury | Dec 22, 2018
Product Development

A year of digital progress at Novartis

...digital therapeutics to improve outcomes in patients with multiple sclerosis, schizophrenia Product March Science 37 Inc. Use Science 37's...
...vs. three to six months,” Liu told BioCentury. The partnership complements a March deal with Science 37 Inc....
...SIX:NOVN), Basel, Switzerland Pear Therapeutics Inc., Boston, Mass. Proteus Digital Health Inc., Redwood City, Calif. Science 37 Inc....
BioCentury | Dec 14, 2018
Company News

Novartis expands patient recruitment capabilities in deal with TrialSpark

...and will initially evaluate an ankylosing spondylitis treatment. Last year, Novartis expanded a collaboration with Science 37 Inc....
Items per page:
1 - 10 of 23